CTOs on the Move

Advantica Benefits

www.advanticabenefits.com

 
Advantica Benefits is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

California Imaging Svc

California Imaging Svc is a Fairfield, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Deerwalk

Deerwalk Incorporated is a revolutionary Population Health Management and Healthcare Analytics Software Company, which offers customers a range of quality products and services to meet their healthcare needs. Deerwalk`s understanding and experience in the Healthcare Analytics industry is unparalleled, offering Big Data and NoSQL products and services to Third Party Administrators, Brokers and Consultants, Employers and Providers, Health Plans, Accountable Care Organizations, Disease / Care Managers, and Health Coaches.

Nucon International Inc

Nucon International Inc is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dickinson Mental Health Center

Dickinson Mental Health Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Dickinson Mental Health Center is based in Ridgway, PA. You can find more information on Dickinson Mental Health Center at www.dmhc.org

Enterin Inc.

Enterin is pioneering the medical community`s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. We are leveraging years of research to become the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha- synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson`s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson`s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis.